home / stock / swtx / swtx articles

SWTX Articles, SpringWorks Therapeutics Inc. - From 06/05/24

Stock Information
Company Name: SpringWorks Therapeutics Inc.
Stock Symbol: SWTX
Market: NYSE
Website: springworkstx.com
Menu
SWTX SWTX Quote SWTX Short SWTX News SWTX Articles SWTX Message Board
Get SWTX Alerts

News, Short Squeeze, Breakout and More Instantly...
SpringWorks Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference | Benzinga

STAMFORD, Conn., June 05, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...
SpringWorks Therapeutics Announces Data to be Presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting | Benzinga

– Results from pivotal Phase 2b ReNeu trial of mirdametinib in patients with NF1-PN to be presented in an oral presentation – – Additional ...

SpringWorks Therapeutics to Participate in the BofA Securities 2024 Health Care Conference | Benzinga

STAMFORD, Conn., May 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company foc...

SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024 | Benzinga

STAMFORD, Conn., April 18, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company f...
SpringWorks Therapeutics to Present at Upcoming Investor Conferences | Benzinga

STAMFORD, Conn., Feb. 22, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...

SpringWorks Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference | Benzinga

STAMFORD, Conn., Jan. 31, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...

SpringWorks Therapeutics Highlights 2023 Accomplishments and Anticipated Milestones for 2024 at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

STAMFORD, Conn., Jan. 08, 2024 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...
SpringWorks Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare Conference | Benzinga

STAMFORD, Conn., Dec. 21, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...

Why SpringWorks Therapeutics Stock (SWTX) Is Nosediving | Benzinga

SpringWorks Therapeutics Inc (NASDAQ: SWTX) shares are trading lower by 8.4% to $29.00 Tuesday morning after the company announced the pricing...

SpringWorks Therapeutics Announces Proposed Public Offering of Common Stock | Benzinga

STAMFORD, Conn., Dec. 04, 2023 (GLOBE NEWSWIRE) -- SpringWorks Therapeutics, Inc. (NASDAQ:SWTX), a commercial-stage biopharmaceutical company fo...
Previous 10 Next 10